Case Studies Flashcards

1
Q

What is WAS?

A

Wiskott-Aldrich Symdrome

caused by mutations in the Wiskott-Aldrich syndrome protein (WASP)
–> nucleation-promoting factors for the ubiquitously expressed Arp2/3 complex, which drives the generation of branched actin filaments

Immune cells (and other cells from the hematopoietic lineage) in patients with WAS have an
impaired ability to reorganize their cytoskeleton

For example, T cells are morphologically
abnormal in patients with WAS, losing their surface microvilli and appearing ‘bald’

The inability of T cells to reorganize their actin cytoskeleton has profound effects on their
function, and thus on the immune system as a whole.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Based on your knowledge of how T cell responses are initiated, how would an impaired ability to reorganize the actin cytoskeleton inhibit T cell activation. What are the implications for impaired proliferative ability for the generation of a T cell
response? (WAS)

A

Poor formation of the immunological synapse:
–> will prevent T cells from clustering receptors together on the cell surface and will impact the signal strength
–> limit T cell activation and proliferation which will then impact the subsequent functions of T cells, limiting cell-cell contacts which are important for
both CD4 and CD8 T cell function

Rearrangement of the cytoskeleton is also important for regulation of the signalling
scaffolding
–> during signalling events; the correct molecules may not be brought into contact with the synapse and therefore limit the generation of a signalling cascade and impact the generation of an effective immune response

impairment in cytoskeleton rearrangement will also
impact phagocytosis
–> impacts antigen presentation and impairs the
ability of APCs to induce T cell activation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Why is cell migration and lymph node organization important for the generation of
immune responses? What impact would impaired T cell migration have on your
ability to respond to infection? (WAS)

A

Lymph node organisation helps cells to find each other and allow for communication between the correct cells at the correct time
Impacting this organisation will inhibit:
–> the development of immune responses by preventing these interactions from occurring in a timely and efficient manner

Migration is impacted, meaning:
–> T cells can’t efficiently circulate between lymph nodes
–> T cells will also struggle to migrate to the B cell follicles preventing T helper cells from communicating with B cells
–> This will in turn prevent class switching and
generation of a robust antibody response as B cells will lack T cell stimulation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What effect would a defect in WASP have on the ability of T cells to direct immune
effector responses?

A
  • T cells migration would be impaired hindering their ability to direct other cells
  • Inability to rearrange cytoskeleton would impact the ability of the T cells to communicate effectively with other cells via cell-cell contact
  • a lack of T reg function might prevent dampening of immune responses leading to
    uncontrolled cellular responses and an increase in autoimmunity

-inability to communicate with B cells, so a lack of isotype switching = inability to effectively produce the correct antobodies to the infection

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Why are patients with WAS more susceptible to viral infections?

A
  • Without the ability to rearrange the cytoskeleton there will be an impairment in contact dependant cytotoxicity in addition to an impairment in CD8 T cell activation and proliferation resulting in an increases susceptibility to intracellular pathogens
  • The cytoskeletal defects will also impact process such as phagocytosis which will impact clearance of infected cells and the ability to present antigens to T cells,
    limiting T cell stimulation further
  • NK cells will also be impacted by this as they will
    not be able to form a good synapse with target cells to release perforin and granzyme
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

If WAS leads to impaired immune responses, can you think why patients with WAS
have higher incidences of allergy and immune-complex mediated diseases?

A

Impairment in T reg function that will inhibit the regulation of abhorrent immune responses

A lack or T regs to control immune responses against allergens will result in an increase in allergy related diseases
–> This could be due to multiple factors and
intrinsic deficiencies within the Treg compartment

A lack of WASP also seems to prevent T cell death upon reactivation and may also lead to activation of T cells that should be killed resulting in an autoimmune response

Immune complexes will cross link receptors which can increase the signalling received to help activate cells even when they cannot form a proper immune
synapse
–> can lead to the formation of allergy and autoimmune responses

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What is EBV?

A

The Epstein–Barr virus

  • one of the most common viruses in humans
  • belongs to the herpesvirus family and causes acute infectious mononucleosis
  • Most people become infected with EBV before
    the age of five and about 90 percent of adults have evidence of previous infection and have gained
    adaptive immunity
  • During childhood, these infections usually cause no symptoms or are indistinguishable from other mild illnesses
  • during adolescence infection causes acute
    infectious mononucleosis in about 50 percent of cases
  • Symptoms include fever (usually lasting for about two weeks), sore throat and swollen glands - usually
    located around the back of the neck but also throughout the body, including substantial spleen
    enlargement
  • exhaustion/fatigue
  • Most symptoms disappear after about 2–3
    weeks and most people are able to resume their normal activities within 2–3 months; however, in some
    cases fatigue may last for up to 2 years
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Cytotoxic CD8+ T cells contribute to immune protection against EBV. How are intracellular
antigens processed and presented to CD8+ T-cells at the cell surface? (EBV)

A
  1. cytosolic protein digested in immunoproteasomes
  2. the peptides, 8-10 amino acids in length, are transported from the cytoplasm into the endoplasmic reticulum (ER) by the transporter associated with antigen processing (TAP) proteins. TAP forms a channel in the ER membrane through which peptides can pass. These are loaded onto newly synthesised MHC class I molecules.
  3. movement through ER, endocytosed (enclosed in vesicle), the subsequently through the GA
  4. vesicle travels to cell membrane where antigen-MHC I complex is presented to a CD8+ T cell
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What do the following
terms mean: MHC restriction; MHC anchor residues; MHC binding motifs; polygenicity; allele
and haplotype? (EBV)

A

MHC restriction:
- CD4 T cells only recognise peptides presented by MHC class II molecules
- CD8 T cells only recognise peptides presented by MHC class I molecules

MHC anchor residues:
- Certain residues on a peptide that have strong binding in pockets in the MHC molecule peptide binding domains

MHC binding motifs:
- Class I molecules have fewer, more specific pockets. As they only bind viral peptides.
- Class II molecules has more, less specific pockets. As they can bind a wide range peptides from many different organisms.

polygenicity:
- a complex genetic trait or phenotype that is influenced by multiple genes, each contributing a small effect to the overall phenotype
- no single gene has a large or dominant effect on the trait; instead, the trait is determined by the combined action of many genes, often interacting with each other and with environmental factors
- eg height, weight, susceptibility to disease

allele:
- a variant form of a gene, which can result in different phenotypic traits or characteristics

haplotype:
- a specific combination of alleles located on the same chromosome, which are inherited together as a unit because they are physically close to each other on the chromosome and are passed down as a unit through generations

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What is clonal expansion? (EBV)

A
  • APCs will present antigen to T cells which will induced a signalling cascade. The T cell will then begin to
    divide multiple times, generating a larger population stemming from a single T cell clone
  • These cells can then polarize and migrate into the periphery to perform their effector function, or go on to generate a pool of memory T cells to response to the same epitope should it be encountered in the future

Methods for studying T cell expansion:

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Which techniques did researchers use prior to the Callan et al. paper to measure the expansion of pathogen-specific CD8+ T cells? (EBV)

A
  • One method used to measure the expansion of pathogen-specific CD8 T cells was the use of an ELISPOT assay, a paper in 1995 (Miyahira et al) says it is an assay based in the detection of IFN-gamma secretion by single cells after their stimulation with antigen
  • The secretion is visualised as spots revealed by using enzyme labelled anti-IFN-gamma monoclonal antibodies
    –> It was determined that the assay detects 80-95% if these CD8 T cells.

Modern method: Flow Cytometry
1. Cell labelling - T cells of interest are isolated from a sample and labelled with fluorescent dyes that bind to specific cell surface markers
- These markers may include CD3, a common marker for T cells, as well as markers specific to certain T cell subsets or activation states

  1. Flow cytometry analysis - The labelled cells are suspended in a fluid stream and passed through a laser beam, causing them to emit fluorescence
    - Detectors measure the intensity of fluorescence emitted by each cell, providing information about the expression levels of the labelled markers.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

How did Callan et al. measure the antigen-specificity of CD8+ T cells during infection? What are
the main advantages of this approach? Are there any drawbacks? (EBV)

A

They used tetramers of MHC molecules complexed to EBV epitopes. These can bind stably and specifically to desired MHC-peptide-specific T cells.

Advantages: Any desired T cell can be measured

Drawbacks: synthesis of the MHC-tetramers seems to be a hard process. Require biotinylation which involves folding, use of protease inhibitors and purification. Yield is 80%.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

How did Callan et al. test the specificity of their tetramers?

A
  1. They used a fluorescent probe to label their synthesised tetrameric complexes and subsequently tested them to see which CD8 T cells that recognised specific sequences bound to them.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Why did Callan et al. measure HLA-DR, CD38, CD62L, CD45RO and CD57? (EBV)

A
  1. These are all different markers indicating levels of CD8 T cell activation. This allowed the researchers to measure the levels of T cells that were activated and antigen specific against EBV
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

The authors find that about 40% of all CD8+ T-cells in the blood of some patients are specific for
one epitope. What are the advantages/disadvantages of such a huge expansion? (EBV)

A
  • As soon as a T cell recognises a presented antigen, it will undergo clonal expanion. This means that the immune system can respond quickly and effectively.
    But if that epitope were to undergo a mutation on reinfection, that large number of T cells would be ineffective
  • Potential for large expansion to target a poorly accessible antigen which might hamper immunity.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

When someone recovers from acute infectious mononucleosis they are considered immune. How
is immunity provided? (EBV)

A

– After the acute infection resolves, a population of long-lived memory B cells is generated
– Memory B cells retain a “memory” of the specific EBV antigens encountered during the initial infection
– In the event of re-exposure to EBV in the future, these memory B cells can quickly recognize and respond to the virus by rapidly differentiating into plasma cells that produce high levels of antibodies
–> This secondary immune response is more rapid and robust compared to the primary response, providing faster and more effective protection against EBV reinfection

– Memory T cells, particularly memory CD8+ T cells, are generated following EBV infection
– These memory T cells persist in the body and can recognize and eliminate EBV-infected cells upon re-exposure to the virus
– This cellular immunity helps prevent EBV reactivation and the development of recurrent infectious mononucleosis

17
Q

What is CVID?

A

Common variable immunodeficiency, also known as hypogammaglobulinemia

CVID is caused by a variety of different genetic abnormalities that result in a defect in the capability of immune cells to produce normal amounts of all types of antibodies

the cause of most cases of CVID is unknown

Many people with CVID carry a polymorphism in a gene known as TACI
–> while this confers increased risk of developing CVID, it alone is not capable of causing CVID

18
Q

What is MS?

A

multiple sclerosis

an autoimmune disease, in which the body’s immune system mistakenly attacks the myelin sheath that surrounds nerve fibres in the central nervous system (CNS)

T cells, become activated and infiltrate the CNS, leading to inflammation and damage to the myelin sheath

This demyelination disrupts nerve signalling and impairs the transmission of electrical impulses between the brain and the rest of the body
–> leads to; fatigue, weakness, numbness or tingling, difficulty walking, vision problems, pain, and cognitive impairment

19
Q

How is CVID treated?

A

treated with a life-long monthly antibody infusions prescription

20
Q

How is MS treated?

A

most common treatment is administering interferons

eg – interferon beta-1a (given by intramuscular or subcutaneous injection) and interferon beta-1b (given by subcutaneous injection)

– These work by reducing inflammation, suppressing the activity of immune cells that contribute to MS pathology, and modulating the expression of pro-inflammatory cytokines

– decrease the frequency and severity of relapses and slow the progression of disability in relapsing-remitting MS (RRMS).